| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | For oral administration |
|
Still deciding? Get samples of US$ 2/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Ambroxol is a clinically proven systemically active mucolytic agent. When administered orally onset of action occurs after about 30 minutes. The breakdown of acid mucopolysaccharide fibers makes the sputum thinner and less viscous and therefore more easily removed by coughing. Although sputum volume eventually decreases, its viscosity remains low for as long as treatment is maintained.
All forms of tracheobronchitis, emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, bronchiectasis, bronchitis with bronchospasm asthma. During acute exacerbations of bronchitis it should be given with the appropriate antibiotic.
Occasional gastrointestinal side effects may occur but these are normally mild.
1. Pregnant and lactating women should use it with caution.
2. Consult your doctor or pharmacist for the dosage for children.
3. It should be avoided to use with central antitussive drugs (such as dextromethorphan, etc.) at the same time, so as to avoid the diluted sputum blocking the airway.
4. This product is a kind of mucus regulator, which only has a certain effect on the symptoms of expectoration. Pay attention to the causes of cough and expectoration when using it. If it does not improve after 7 days, seek medical advice in time.
5. In case of overdose or serious adverse reactions, seek medical advice immediately.
6. It is forbidden to use this product for people with allergic constitution.
7. It is forbidden to use when the character of the product changes.
8. Please keep this product out of the reach of children.
9. Children must use it under the supervision of adults.
10. If you are using other drugs, please consult your doctor or pharmacist before using this product.
){kind=link}